Jerry G Henslee

Title: Jerry G Henslee: Innovator in Tumor Detection and Immunoassay Methods

Introduction

Jerry G Henslee is a notable inventor based in Libertyville, IL (US), recognized for his contributions to the fields of tumor detection and immunoassay methods. With a total of 2 patents, Henslee has made significant advancements that have the potential to improve patient outcomes in cancer diagnosis and monitoring.

Latest Patents

Henslee's latest patents include a method of detecting tumors containing complexes of p53 and HSP70. This invention relates to the discovery that a specific class of mutant p53 proteins, which bind to HSP70, can elicit serum autoantibodies. The patent outlines methods for classifying tumor cells based on their ability to produce serum p53 autoantibodies, detecting tumor cells with mutant p53 proteins, distinguishing aggressive tumor cells, and monitoring patients for disease recurrence. Another significant patent is for the detection of altered IgA1 in fluid samples. This novel immunoassay method focuses on detecting the immunoglobulin IgA1 with O-linked oligosaccharides lacking sialic acid in various fluid samples, including blood, serum, and plasma.

Career Highlights

Throughout his career, Henslee has worked with prestigious institutions, including Duke University and Abbott Laboratories Corporation. His work has contributed to the advancement of medical diagnostics and has had a lasting impact on the field.

Collaborations

Henslee has collaborated with notable professionals in his field, including Jeffrey R Marks and James Dirk Inglehart. These collaborations have further enhanced the quality and reach of his innovative work.

Conclusion

Jerry G Henslee is a distinguished inventor whose work in tumor detection and immunoassay methods has the potential to transform cancer diagnostics. His contributions are invaluable to the medical community and continue to pave the way for future innovations.